Memantine vs Rituximab

## Memantine vs Rituximab: Overview

This comparison examines the pharmacological differences between **Memantine** and **Rituximab**.

## Mechanism of Action

**Memantine**: Non-competitive NMDA receptor antagonist.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Memantine — 60-80 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Memantine — C12H21N; Rituximab — N/A.

**Molecular Weight**: Memantine — 179.3080 g/mol; Rituximab — N/A.

**Type**: Memantine — Small molecule; Rituximab — Antibody.